Morgan Stanley’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $98.8M | Buy |
|
|||||
|
2023
Q3 | $8.74M | Sell |
|
|||||
|
2023
Q2 | $22.6M | Buy |
|
|||||
|
2023
Q1 | $16.9M | Sell |
|
|||||
|
2022
Q4 | $22M | Sell |
|
|||||
|
2022
Q3 | $32.9M | Sell |
|
|||||
|
2022
Q2 | $19.3M | Buy |
|
|||||
|
2022
Q1 | $16.6M | Buy |
|
|||||
|
2021
Q4 | $10.3M | Buy |
|
|||||
|
2021
Q3 | $6.05M | Sell |
|
|||||
|
2021
Q2 | $8.34M | Sell |
|
|||||
|
2021
Q1 | $11.9M | Buy |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $315K | Sell |
|
|||||
|
2020
Q2 | $961K | Buy |
|
|||||
|
2020
Q1 | $141K | Sell |
|
|||||
|
2019
Q4 | $614K | Buy |
|
|||||
|
2019
Q3 | $32K | Buy |
|